2023 Q2 Form 10-Q Financial Statement

#000113754723000025 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $767.0K $734.0K
YoY Change -93.02% -92.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $364.0K $376.0K
YoY Change 15.19% 20.9%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $2.582M $1.614M
YoY Change 342.12% 191.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $6.217M $8.646M
YoY Change 28.74% 153.47%
Income Tax $1.800M $2.521M
% Of Pretax Income 28.95% 29.16%
Net Earnings $4.417M $6.125M
YoY Change 28.59% 150.72%
Net Earnings / Revenue 575.88% 834.47%
Basic Earnings Per Share $0.26 $0.36
Diluted Earnings Per Share $0.26 $0.36
COMMON SHARES
Basic Shares Outstanding 17.09M shares 17.15M shares
Diluted Shares Outstanding 17.11M shares 17.09M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $58.40M $45.15M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $10.99M $11.29M
YoY Change -3.22% -0.61%
Goodwill $4.500M $4.500M
YoY Change 0.27% 0.27%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.35M $14.42M
YoY Change 52.18% 106.8%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.289B $1.261B
YoY Change -3.78% -6.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.759M $1.915M
YoY Change -26.74% -25.02%
Deferred Revenue
YoY Change
Short-Term Debt $100.6M $13.20M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $102.4M $15.11M
YoY Change 4164.01% 491.82%
LONG-TERM LIABILITIES
Long-Term Debt $10.72M $11.02M
YoY Change 2.19% 1.19%
Other Long-Term Liabilities $13.49M $11.02M
YoY Change 59.95% 30.36%
Total Long-Term Liabilities $24.21M $22.04M
YoY Change 27.93% 13.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $102.4M $15.11M
Total Long-Term Liabilities $24.21M $22.04M
Total Liabilities $1.173B $1.148B
YoY Change -4.59% -7.11%
SHAREHOLDERS EQUITY
Retained Earnings $71.86M $69.50M
YoY Change 12.5% 11.53%
Common Stock $60.45M $60.27M
YoY Change 1.03% 0.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $115.7M $112.9M
YoY Change
Total Liabilities & Shareholders Equity $1.289B $1.261B
YoY Change -3.78% -6.56%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $4.417M $6.125M
YoY Change 28.59% 150.72%
Depreciation, Depletion And Amortization $364.0K $376.0K
YoY Change 15.19% 20.9%
Cash From Operating Activities $8.326M $9.328M
YoY Change 50.72% 313.66%
INVESTING ACTIVITIES
Capital Expenditures $218.0K $92.00K
YoY Change -146.88% -67.26%
Acquisitions
YoY Change
Other Investing Activities -$15.93M $40.35M
YoY Change -86.12% -295.74%
Cash From Investing Activities -$16.14M $40.26M
YoY Change -85.99% -292.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.07M -$43.03M
YoY Change -362.91% -276.67%
NET CHANGE
Cash From Operating Activities 8.326M $9.328M
Cash From Investing Activities -16.14M $40.26M
Cash From Financing Activities 21.07M -$43.03M
Net Change In Cash 13.25M $6.558M
YoY Change -111.26% 14.75%
FREE CASH FLOW
Cash From Operating Activities $8.326M $9.328M
Capital Expenditures $218.0K $92.00K
Free Cash Flow $8.108M $9.236M
YoY Change 35.38% 367.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001137547
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
944191000 usd
CY2022Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
981772000 usd
CY2023Q1 dei Entity File Number
EntityFileNumber
000-32897
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
UNITED SECURITY BANCSHARES
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-2112732
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2126 Inyo Street
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Fresno
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93721
CY2023Q1 dei City Area Code
CityAreaCode
559
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
248-4943
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2023Q1 dei Trading Symbol
TradingSymbol
UBFO
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17094298 shares
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
41949000 usd
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
31650000 usd
CY2023Q1 ubfo Due From Frb Interest Bearing Cash
DueFromFrbInterestBearingCash
3204000 usd
CY2022Q4 ubfo Due From Frb Interest Bearing Cash
DueFromFrbInterestBearingCash
6945000 usd
CY2023Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
45153000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
38595000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
205556000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
207545000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3358000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3315000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
208914000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
210860000 usd
CY2023Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-1464000 usd
CY2022Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-1594000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15622000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10182000 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
927105000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
969996000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9486000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9770000 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
7829000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
8489000 usd
CY2023Q1 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
4582000 usd
CY2022Q4 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
4582000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
4488000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4488000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14422000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12825000 usd
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
23025000 usd
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
22893000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1808000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1984000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
14382000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
14711000 usd
CY2023Q1 us-gaap Assets
Assets
1261194000 usd
CY2022Q4 us-gaap Assets
Assets
1299193000 usd
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
394745000 usd
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
481629000 usd
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
716387000 usd
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
683855000 usd
CY2023Q1 us-gaap Deposits
Deposits
1111132000 usd
CY2022Q4 us-gaap Deposits
Deposits
1165484000 usd
CY2023Q1 us-gaap Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
13200000 usd
CY2022Q4 us-gaap Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
0 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1915000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2093000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
11022000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
8270000 usd
CY2023Q1 us-gaap Subordinated Debt
SubordinatedDebt
11017000 usd
CY2022Q4 us-gaap Subordinated Debt
SubordinatedDebt
10883000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1148286000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1186730000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17094298 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17094298 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17067253 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17067253 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
60269000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
60030000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
69495000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
69928000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16856000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17495000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
112908000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
112463000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1261194000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1299193000 usd
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
13000000 usd
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
9119000 usd
CY2023Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1501000 usd
CY2022Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
790000 usd
CY2023Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
58000 usd
CY2022Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
82000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
14559000 usd
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9991000 usd
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1343000 usd
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
508000 usd
CY2023Q1 us-gaap Interest Expense Loans From Other Federal Home Loan Banks
InterestExpenseLoansFromOtherFederalHomeLoanBanks
271000 usd
CY2022Q1 us-gaap Interest Expense Loans From Other Federal Home Loan Banks
InterestExpenseLoansFromOtherFederalHomeLoanBanks
45000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1614000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
553000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12945000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9438000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-493000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
5000 usd
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
13438000 usd
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
9433000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
734000 usd
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
5816000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8646000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
654000 usd
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
132000 usd
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
139000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
43000 usd
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-182000 usd
CY2023Q1 ubfo Gain Losson Fair Value Optionof Financial Liability
GainLossonFairValueOptionofFinancialLiability
333000 usd
CY2022Q1 ubfo Gain Losson Fair Value Optionof Financial Liability
GainLossonFairValueOptionofFinancialLiability
-999000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
0 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
30000 usd
CY2023Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
206000 usd
CY2022Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
152000 usd
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
1448000 usd
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
-206000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3260000 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3049000 usd
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
963000 usd
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
780000 usd
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
174000 usd
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
115000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
882000 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
949000 usd
CY2023Q1 ubfo Regulatory Assessments Expense Benefit
RegulatoryAssessmentsExpenseBenefit
192000 usd
CY2022Q1 ubfo Regulatory Assessments Expense Benefit
RegulatoryAssessmentsExpenseBenefit
231000 usd
CY2023Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
109000 usd
CY2022Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
118000 usd
CY2023Q1 ubfo Correspondent Bank Service Charges
CorrespondentBankServiceCharges
19000 usd
CY2022Q1 ubfo Correspondent Bank Service Charges
CorrespondentBankServiceCharges
25000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-37000 usd
CY2022Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
8000 usd
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
604000 usd
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
557000 usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
6240000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3411000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2521000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
968000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6125000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2443000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17076510 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17030409 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17092460 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17051819 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6125000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2443000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1325000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-11689000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
21000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
23000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
-440000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax
1302000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
906000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-10364000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
390000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-3455000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
7000 usd
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
7000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodTax
-130000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodTax
385000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
639000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7301000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6764000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4858000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
120207000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7301000 usd
CY2022Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1874000 usd
CY2022Q1 ubfo Stockholders Equity Tax Benefit From Restricted Stock Units Released
StockholdersEquityTaxBenefitFromRestrictedStockUnitsReleased
1000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
48000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
53000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2443000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
113575000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5235000 usd
CY2022Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1875000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
47000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
53000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
3435000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
110000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5601000 usd
CY2022Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2022Q3 us-gaap Dividends Common Stock
DividendsCommonStock
1877000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
44000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4467000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
107078000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1816000 usd
CY2022Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2022Q4 us-gaap Dividends Common Stock
DividendsCommonStock
1878000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
42000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
5341000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
112463000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
639000 usd
CY2023Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.11
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1880000 usd
CY2023Q1 ubfo Stockholders Equity Tax Benefit From Restricted Stock Units Released
StockholdersEquityTaxBenefitFromRestrictedStockUnitsReleased
10000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
208000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6125000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
112908000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
41424 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
27949 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
26949 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
26949 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
29449 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
13974 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6125000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-248000 usd
CY2023Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-130000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2443000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-493000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
5000 usd
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
376000 usd
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
311000 usd
CY2023Q1 ubfo Increase Decrease In Operating Leases Right Of Use Assets
IncreaseDecreaseInOperatingLeasesRightOfUseAssets
176000 usd
CY2022Q1 ubfo Increase Decrease In Operating Leases Right Of Use Assets
IncreaseDecreaseInOperatingLeasesRightOfUseAssets
151000 usd
CY2023Q1 ubfo Amortizationof Investment Securities
AmortizationofInvestmentSecurities
111000 usd
CY2022Q1 ubfo Amortizationof Investment Securities
AmortizationofInvestmentSecurities
197000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
0 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
30000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-660000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
271000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-17000 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2539000 usd
CY2022Q1 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-219000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
355000 usd
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1263000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
43000 usd
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-182000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
240000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
100000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-32000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
89000 usd
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
132000 usd
CY2022Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
139000 usd
CY2023Q1 ubfo Gain Loss On Fair Value Of Financial Instruments Net Pretax
GainLossOnFairValueOfFinancialInstrumentsNetPretax
333000 usd
CY2022Q1 ubfo Gain Loss On Fair Value Of Financial Instruments Net Pretax
GainLossOnFairValueOfFinancialInstrumentsNetPretax
-999000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-636000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2577000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9328000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2225000 usd
CY2023Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
2000 usd
CY2022Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
6000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
34734000 usd
CY2023Q1 ubfo Principal Paymentsof Availablefor Sale Securities
PrincipalPaymentsofAvailableforSaleSecurities
3203000 usd
CY2022Q1 ubfo Principal Paymentsof Availablefor Sale Securities
PrincipalPaymentsofAvailableforSaleSecurities
6140000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
15676000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Loans And Leases Held For Investment
ProceedsFromSaleOfLoansAndLeasesHeldForInvestment
37146000 usd
CY2022Q1 us-gaap Payments To Acquire Loans And Leases Held For Investment
PaymentsToAcquireLoansAndLeasesHeldForInvestment
7689000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
281000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
40255000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20894000 usd
CY2023Q1 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
-65912000 usd
CY2022Q1 us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
29178000 usd
CY2023Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
11561000 usd
CY2022Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-2952000 usd
CY2023Q1 us-gaap Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net
IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet
13200000 usd
CY2022Q1 us-gaap Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net
IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet
0 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1874000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1872000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43025000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24354000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6558000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5715000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38595000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219219000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45153000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
224934000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
231296000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
23000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
25763000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
205556000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
234610000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
17000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
27082000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
207545000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
17506000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
17272000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
31772000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
30280000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
65908000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
55411000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
7700000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
6791000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
108410000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
95802000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
231296000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
205556000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
15676000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
78000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
48000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
52342000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
3356000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
147609000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
22407000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
199951000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
25763000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
87106000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5630000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
114717000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
21452000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
201823000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
27082000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
114 security
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
90 security
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
43000 usd
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-182000 usd
CY2023Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0 usd
CY2023Q1 us-gaap Trading Securities
TradingSecurities
0 usd
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0 usd
CY2022Q4 us-gaap Trading Securities
TradingSecurities
0 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
942727000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
980178000 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
942727000 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
382000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
980178000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
252000 usd
CY2023Q1 ubfo Period Of Default Minimum
PeriodOfDefaultMinimum
P90D
CY2023Q1 ubfo Number Of Monthly Payments To Demonstrate Repayment Ability
NumberOfMonthlyPaymentsToDemonstrateRepaymentAbility
6 payment
CY2022 ubfo Financing Receivable Remaining Undisbursed Commitments Loan Funds
FinancingReceivableRemainingUndisbursedCommitmentsLoanFunds
0 usd
CY2023Q1 ubfo Financing Receivable Remaining Undisbursed Commitments Loan Funds
FinancingReceivableRemainingUndisbursedCommitmentsLoanFunds
0 usd
CY2023Q1 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
13109000 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
13195000 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
382000 usd
CY2022Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
14436000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
14544000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
252000 usd
CY2023Q1 ubfo Number Of Risk Rating Approaches
NumberOfRiskRatingApproaches
2 rating
CY2023Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
3974000 usd
CY2023Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
118744000 usd
CY2023Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
250346000 usd
CY2023Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
74767000 usd
CY2023Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
63867000 usd
CY2023Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
183780000 usd
CY2023Q1 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
203630000 usd
CY2023Q1 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
0 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
942727000 usd
CY2022Q4 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
126266000 usd
CY2022Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
253353000 usd
CY2022Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
78648000 usd
CY2022Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
68320000 usd
CY2022Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
46435000 usd
CY2022Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
159501000 usd
CY2022Q4 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
247655000 usd
CY2022Q4 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
0 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
980178000 usd
CY2023Q1 ubfo Numberof Loan Portfolio Segment
NumberofLoanPortfolioSegment
10 segment
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10182000 usd
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
493000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
477000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
43000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
434000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15622000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9333000 usd
CY2022Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-5000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
358000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
296000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
62000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9276000 usd
CY2023Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
14062000 usd
CY2023Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
928665000 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
942727000 usd
CY2022Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
11945000 usd
CY2022Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
865018000 usd
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
876963000 usd
CY2022Q4 us-gaap Deposits
Deposits
1165484000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
178000 usd
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
394745000 usd
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
481629000 usd
CY2023Q1 us-gaap Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now
DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW
528233000 usd
CY2022Q4 us-gaap Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now
DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW
499861000 usd
CY2023Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
118544000 usd
CY2022Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
125946000 usd
CY2023Q1 ubfo Time Deposits Less Than250000
TimeDepositsLessThan250000
52835000 usd
CY2022Q4 ubfo Time Deposits Less Than250000
TimeDepositsLessThan250000
42933000 usd
CY2023Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
16775000 usd
CY2022Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
15115000 usd
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
716387000 usd
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
683855000 usd
CY2023Q1 us-gaap Deposits
Deposits
1111132000 usd
CY2023Q1 us-gaap Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
13200000 usd
CY2022Q4 us-gaap Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
0 usd
CY2023Q1 ubfo Lessee Operating Lease Number Of Contracts
LesseeOperatingLeaseNumberOfContracts
14 contract
CY2023Q1 ubfo Lessee Financing Lease Number Of Contracts
LesseeFinancingLeaseNumberOfContracts
0 contract
CY2022Q1 ubfo Lessee Operating Lease Number Of Contracts
LesseeOperatingLeaseNumberOfContracts
13 contract
CY2022Q1 ubfo Lessee Financing Lease Number Of Contracts
LesseeFinancingLeaseNumberOfContracts
0 contract
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
184000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
178000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
184000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
179000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
184000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y4M17D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M20D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0512
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0513
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
723000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
519000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
335000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
159000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
110000 usd
CY2023Q1 ubfo Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
291000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2137000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
222000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1915000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1631000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
554000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 ubfo Cumulative Effect Of Change In Accounting Principle
CumulativeEffectOfChangeInAccountingPrinciple
6367000 usd
CY2022Q1 ubfo Cumulative Effect Of Change In Accounting Principle
CumulativeEffectOfChangeInAccountingPrinciple
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
21000 usd
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
23000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1325000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-11689000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
2947000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
1302000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1880000 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1875000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
CY2023Q1 ubfo Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
1900000 usd
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6125000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2443000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17076510 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17030409 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15950 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
21410 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17092460 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17051819 shares
CY2023Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
-107000 usd
CY2022Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
303000 usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
101000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
97000 shares
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2521000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
968000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.292
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.284
CY2023Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
-107000 usd
CY2023Q1 ubfo Fair Value Option Credit Risk Gross Gain On Assets
FairValueOptionCreditRiskGrossGainOnAssets
333000 usd
CY2023Q1 ubfo Fair Value Option Credit Risk Gain On Assets Net
FairValueOptionCreditRiskGainOnAssetsNet
235000 usd
CY2023Q1 ubfo Fair Value Option Credit Risk Gain Loss On Assets Net Before Tax
FairValueOptionCreditRiskGainLossOnAssetsNetBeforeTax
-440000 usd
CY2023Q1 ubfo Fair Value Option Credit Risk Loss On Assets Net
FairValueOptionCreditRiskLossOnAssetsNet
-310000 usd
CY2022Q1 us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
303000 usd
CY2022Q1 ubfo Fair Value Option Credit Risk Gross Gain On Assets
FairValueOptionCreditRiskGrossGainOnAssets
1302000 usd
CY2022Q1 ubfo Fair Value Option Credit Risk Gain On Assets Net
FairValueOptionCreditRiskGainOnAssetsNet
917000 usd
CY2022Q1 ubfo Fair Value Option Credit Risk Gain Loss On Assets Net Before Tax
FairValueOptionCreditRiskGainLossOnAssetsNetBeforeTax
-999000 usd
CY2022Q1 ubfo Fair Value Option Credit Risk Loss On Assets Net
FairValueOptionCreditRiskLossOnAssetsNet
-704000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
4500000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4500000 usd
CY2023Q1 ubfo Minimum Term Of Guarantees
MinimumTermOfGuarantees
P1M
CY2023Q1 ubfo Maximum Term Of Guarantees
MaximumTermOfGuarantees
P3Y

Files In Submission

Name View Source Status
ubfo-20230331_cal.xml Edgar Link unprocessable
0001137547-23-000025-index-headers.html Edgar Link pending
0001137547-23-000025-index.html Edgar Link pending
0001137547-23-000025.txt Edgar Link pending
0001137547-23-000025-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ubfo-20230331.htm Edgar Link pending
ubfo-20230331.xsd Edgar Link pending
ubfo-20230331exhibit311.htm Edgar Link pending
ubfo-20230331exhibit312.htm Edgar Link pending
ubfo-20230331exhibit321.htm Edgar Link pending
ubfo-20230331exhibit322.htm Edgar Link pending
ubfo-20230331_def.xml Edgar Link unprocessable
ubfo-20230331_lab.xml Edgar Link unprocessable
ubfo-20230331_pre.xml Edgar Link unprocessable
ubfo-20230331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable